CKW Financial Group’s Novartis NVS Stock Holding History

CKW Financial Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-700	Closed	-$68K	–	232
2024 Q4	$68K	Hold	700	–	–	0.01%	112
2024 Q3	$80K	Sell	700 -100	-13%	-$11.3K	0.01%	110
2024 Q2	$85K	Hold	800	–	–	0.01%	105
2024 Q1	$77K	Hold	800	–	–	0.01%	118
2023 Q4	$81K	Sell	800 -400	-33%	-$38.6K	0.01%	113
2023 Q3	$122K	Hold	1,200	–	–	0.02%	72
2023 Q2	$121K	Hold	1,200	–	–	0.02%	74
2023 Q1	$110K	Hold	1,200	–	–	0.02%	62
2022 Q4	$109K	Hold	1,200	–	–	0.02%	63
2022 Q3	$91K	Sell	1,200 -100	-8%	-$8.29K	0.02%	78
2022 Q2	$110K	Sell	1,300 -400	-24%	-$35.1K	0.02%	68
2022 Q1	$149K	Buy	1,700 +138	+9%	+$11.9K	0.02%	63
2021 Q4	$140K	Sell	1,562 -100	-6%	-$8.3K	0.02%	61
2021 Q3	$136K	Buy	1,662 +450	+37%	+$40.5K	0.02%	61
2021 Q2	$111K	Buy	1,212 +212	+21%	+$18.9K	0.02%	72
2021 Q1	$85K	Hold	1,000	–	–	0.01%	76
2020 Q4	$94K	Sell	1,000 -250	-20%	-$21.8K	0.02%	72
2020 Q3	$109K	Buy	1,250 +100	+9%	+$8.66K	0.02%	58
2020 Q2	$101K	Sell	1,150 -200	-15%	-$17.3K	0.02%	53
2020 Q1	$109K	Hold	1,350	–	–	0.03%	45
2019 Q4	$128K	Hold	1,350	–	–	0.02%	55
2019 Q3	$116K	Sell	1,350 -150	-10%	-$13.5K	0.02%	53
2019 Q2	$137K	Sell	1,500 -397	-21%	-$33.6K	0.03%	49
2019 Q1	$163K	Hold	1,897	–	–	0.03%	38
2018 Q4	$146K	Sell	1,897 -223	-11%	-$17.4K	0.03%	35
2018 Q3	$164K	Hold	2,120	–	–	0.03%	35
2018 Q2	$144K	Hold	2,120	–	–	0.03%	39
2018 Q1	$151K	Hold	2,120	–	–	0.03%	31
2017 Q4	$160K	Hold	2,120	–	–	0.04%	31
2017 Q3	$163K	Sell	2,120 -224	-10%	-$16.9K	0.04%	33
2017 Q2	$176K	Hold	2,344	–	–	0.05%	32
2017 Q1	$156K	Buy	2,344 +558	+31%	+$37.2K	0.05%	40
2016 Q4	$117K	Hold	1,786	–	–	0.04%	49
2016 Q3	$126K	Hold	1,786	–	–	0.04%	45
2016 Q2	$132K	Hold	1,786	–	–	0.05%	39
2016 Q1	$116K	Hold	1,786	–	–	0.04%	44
2015 Q4	$138K	Sell	1,786 -111	-6%	-$8.82K	0.05%	36
2015 Q3	$156K	Sell	1,897 -1,059	-36%	-$94.2K	0.06%	29
2015 Q2	$261K	Sell	2,956 -332	-10%	-$30.5K	0.1%	19
2015 Q1	$294K	Buy	3,288 +148	+5%	+$13.1K	0.12%	18
2014 Q4	$2.26M	Hold	3,140	–	–	0.95%	7
2014 Q3	$265K	Hold	3,140	–	–	0.12%	17
2014 Q2	$257K	Buy	3,140 +111	+4%	+$8.73K	0.14%	18
2014 Q1	$226K	Buy	3,029 +59	+2%	+$4.3K	0.11%	24
2013 Q4	$214K	Buy	+2,970	New	+$206K	0.11%	23

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CKW Financial Group's NVS Position: Q1 2025 in Review

CKW Financial Group sold out of Novartis (NVS) in Q1 2025, closing a stake of 700 shares — an estimated $68K sold.

CKW Financial Group first reported a position in NVS in Q4 2013 and held it in 45 quarters. The position peaked at $2.26M in Q4 2014. 1,356 funds tracked by Wall St. Rank hold NVS as of Q1 2025.

CKW Financial Group reported no remaining Novartis position as of Q1 2025 after selling out during the quarter.
CKW Financial Group sold 700 Novartis shares in Q1 2025, an estimated $68K.
CKW Financial Group first reported a position in Novartis in Q4 2013 and held it in 45 quarters.
CKW Financial Group's Novartis position peaked at $2.26M in Q4 2014.
1,356 funds tracked by Wall St. Rank held Novartis as of Q1 2025.

Based on CKW Financial Group's 13F filing for Q1 2025, filed 16 May 2025.